Binhui Biopharmaceutical Co., Ltd.

This early-stage trial is testing an investigational therapy called OH2, a modified herpes simplex virus designed to infect and destroy cancer cells while also stimulating the immune system. The study will evaluate OH2 alone or in combination with the immunotherapy drug pembroliz…

This trial is testing an experimental treatment called OH2, a modified herpes simplex virus, for people with recurrent central nervous system tumors, including glioblastoma. The virus is injected into the tumor cavity after surgery to see if it can safely attack cancer cells and …